Focuses on the lack of funding of VaxGen Inc. for phase four of the clinical trials according to a report written by Victoria Stagg Elliott in "American Medical News." Variance in drug reaction among ethnicities; Evidence of increased risks of certain diseases among ethnic groups; Changes in DNA after a long length of time.